Recent studies implied that CD73 was over-expressed on various kinds of solid malignant tumors (i.e., breast cancer [2], colorectal cancer [3], prostate cancer [4], ovarian cancer [5], and gallbladder cancer [6]). The gene discussed is NT5E; the disease is prostate carcinoma.